Back to GetFilings.com








U.S. SECURITIES AND EXCHANGE COMMISSION
 
WASHINGTON, D.C. 20549
 
FORM 10-Q
 
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
 
For The Quarterly Period Ended
March 31, 2005
 
 
Commission file number: 0-30391
 
MEDIS TECHNOLOGIES LTD.
(Exact Name of Registrant as Specified in its Charter)
 

Delaware 
13-3669062 
(State or other jurisdiction of  
(I.R.S. Employer 
incorporation or organization) 
Identification Number) 
 
 
805 Third Avenue
New York, New York 10022
(Address of Principal Executive Offices and Zip Code)
 
(212) 935-8484
(Registrant's Telephone Number, Including Area Code)
 
Indicate by checkmark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
  Yes x     No o  


Indicate by checkmark whether the registrant is an accelerated filer as defined in Rule 12b-2 of the Exchange Act.
  Yes x    No o
The number of shares of Common Stock, par value $.01 per share, outstanding as of May 6, 2005 was 27,304,167.







MEDIS TECHNOLOGIES LTD.

INDEX TO FORM 10-Q

FOR THE QUARTER ENDED MARCH 31, 2005

PART I.
 
FINANCIAL INFORMATION
 
Page Number
 
Item 1.
 
Financial Statements
 
 
 
Condensed Consolidated Balance Sheets
 
 
December 31, 2004 and March 31, 2005 (Unaudited)
 
1
 
 
Condensed Consolidated Statements of Operations (Unaudited)
 
 
Three months ended March 31, 2004 and 2005
 
2
 
 
Condensed Consolidated Statements of Cash Flows (Unaudited)
 
 
Three months ended March 31, 2004 and 2005
 
3
 
 
Notes to Condensed Consolidated Financial Statements (Unaudited)
 
4
 
Item 2.
Management’s Discussion and Analysis of Financial
 
 
Condition and Results of Operations
 
8
 
Item 3.
 
Quantitative and Qualitative Disclosures About Market Risk
 
12
 
Item 4.
 
Controls and Procedures
 
13
 
PART II.
 
OTHER INFORMATION
 
 
Item 2.
 
Unregistered Sales of Equity Securities and Use of Proceeds 14
Item 5.
 
Other Information  14
Item 6.
 
Exhibits
 
14
 

 




PART I - FINANCIAL INFORMATION
 
Item 1.  Financial Statements
 
Medis Technologies Ltd. and Subsidiaries
Condensed Consolidated Balance Sheets


   
December 31, 2004
 
March 31, 2005
 
       
(unaudited)
 
ASSETS
         
Current assets
         
Cash and cash equivalents
 
$
15,758,000
 
$
12,734,000
 
Accounts receivable—other
   
325,000
   
458,000
 
Prepaid expenses and other current assets
   
162,000
   
137,000
 
Total current assets
   
16,245,000
   
13,329,000
 
Property and equipment, net
   
3,493,000
   
4,005,000
 
Long-term note
   
299,000
   
301,000
 
Severance pay fund
   
859,000
   
902,000
 
Intangible assets, net
   
672,000
   
620,000
 
Goodwill, net
   
58,205,000
   
58,205,000
 
Total assets
 
$
79,773,000
 
$
77,362,000
 
 
LIABILITIES AND
STOCKHOLDERS’ EQUITY
             
Current liabilities
             
Accounts payable
 
$
1,128,000
 
$
1,270,000
 
Accrued expenses and other current liabilities
   
2,583,000
   
2,802,000
 
Total current liabilities
   
3,711,000
   
4,072,000
 
Leasehold incentive obligations
   
748,000
   
701,000
 
Accrued severance pay
   
1,451,000
   
1,531,000
 
Commitments and contingent liabilities
             
Stockholders’ equity
             
Preferred stock, $.01 par value; 10,000 shares authorized; none issued
   
   
 
Common stock, $.01 par value; 38,000,000 shares authorized;
27,016,819 and 27,220,624 shares issued and outstanding, at
December 31, 2004 and March 31, 2005, respectively
   
270,000
   
272,000
 
Additional paid-in capital
   
198,774,000
   
200,935,000
 
Accumulated deficit
   
(125,181,000
)
 
(130,149,000
)
Total stockholders’ equity
   
73,863,000
   
71,058,000
 
Total liabilities and stockholders’ equity
 
$
79,773,000
 
$
77,362,000
 

 
The accompanying notes are an integral part of these condensed consolidated financial statements.

 
1



Medis Technologies Ltd. and Subsidiaries
Condensed Consolidated Statements of Operations
(Unaudited)

   
Three Months Ended March 31,
 
   
2004
 
2005
 
 
Operating expenses
         
Research and development costs, net
 
$
1,918,000
 
$
3,740,000
 
Selling, marketing, general and administrative expenses
   
1,330,000
   
1,249,000
 
Amortization of intangible assets
   
52,000
   
52,000
 
Total operating expenses
   
3,300,000
   
5,041,000
 
Loss from operations
   
(3,300,000
)
 
(5,041,000
)
Other income (expenses)
             
Interest income
   
64,000
   
78,000
 
Interest expense
   
(5,000
)
 
(5,000
)
     
59,000
   
73,000
 
NET LOSS
 
$
(3,241,000
)
$
(4,968,000
)
 
Basic and diluted net loss per share
 
$
(.13
)
$
(.18
)
 
Weighted-average number of common shares used in computing basic and diluted net loss per share
   
25,880,979
   
27,087,934
 
   







The accompanying notes are an integral part of these condensed consolidated financial statements.


2


Medis Technologies Ltd. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(Unaudited)

   
Three Months Ended March 31,
 
   
2004
 
2005
 
 
Cash flows from operating activities
         
Net loss
 
$
(3,241,000
)
$
(4,968,000
)
Adjustments to reconcile net loss to net cash used in operating activities
             
Depreciation and amortization of property and
equipment
   
117,000
   
183,000
 
Amortization of intangible assets
   
52,000
   
52,000
 
Non-cash stock based compensation expense
   
300,000
   
61,000
 
Changes in operating assets and liabilities
             
Accounts receivable—trade
   
74,000
   
 
Accounts receivable—other
   
(29,000
)
 
(135,000
)
Prepaid expenses and other current assets
   
62,000
   
25,000
 
Accounts payable
   
206,000
   
192,000
 
Accrued expenses and other current liabilities
   
186,000
   
247,000
 
Leasehold incentive obligations
   
   
(47,000
)
Accrued severance pay, net